Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 9Recruiting 5Unknown 2Not yet recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 3Gynecologic 3Head & Neck 2Genitourinary 2Thoracic 1Plasma cell 1Gastrointestinal 1Dermatologic 1Classical hematology 1

Conditions

Nasopharyngeal Carcinoma 1Head and Neck Neoplasms 1

Interventions

Cisplatin 28toripalimab 14Radiotherapy 12Gemcitabine 12Capecitabine 11Radiotherapy, Intensity-Modulated 10pembrolizumab 9Surgical Procedures, Operative 9Docetaxel 9tislelizumab 8Carboplatin 7Drug Therapy 6Blood Specimen Collection 6anlotinib 5Taxes 5Paclitaxel 5Nivolumab 5Fluorouracil 5Cetuximab 5130-nm albumin-bound paclitaxel 5Thyroxine 4Magnetic Resonance Spectroscopy 4Cyclophosphamide 4trametinib 3sintilimab 3camrelizumab 3Radiation 3Observation 3Injections 3Immune Checkpoint Inhibitors 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Therapeutics × Head & Neck × Clear all
NCT07524894 2026-05-01

SNIFF

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Not yet recruiting
126 enrolled
Head & Neck

Head and Neck Neoplasms

NCT06781112 2025-01-17

A Phase II Study of TPF With PD-1 Inhibitor Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma

Chengdu University of Traditional Chinese Medicine

Phase 2 Not yet recruiting
35 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡